NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Bevacizumab is a medication used in cancer treatment to slow down the growth of tumors by blocking the formation of new blood vessels. It is most commonly used to treat non-small cell lung cancer, although it has been approved for other types of cancer as well. Options B, C, and D are incorrect because Bevacizumab is not commonly used to treat ovarian cancer, prostate cancer, or melanoma. While Bevacizumab may be used in some cases as part of a treatment plan for these types of cancer, it is not the primary or most commonly used medication. Therefore, option A is the most appropriate and accurate answer.